Top compounds associated with response to OR2T4


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.09
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.053 0.09
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.088 0.09
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.058 0.09
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.09
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.051 0.1
mRNA lapatinib CTRPv2 pan-cancer AAC -0.057 0.1
mRNA BX-912 GDSC1000 pan-cancer AAC 0.048 0.1
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.062 0.1
mRNA MS-275 gCSI pan-cancer AAC 0.083 0.1
Download CSV